Terms of Use

Shire is pleased to provide you with this web site and its content for general informational purposes. Please carefully read these Terms and Conditions relating to the use of our web site. Shire will use reasonable efforts to ensure that the information is accurate at the time it is added to the web site. Please note, however, that Shire makes no warranties or representations that the information is accurate and accepts no liability for any errors or omissions in the content of the site or any losses or damage that may arise from relying on this information. The information may be changed by Shire at any time. By using this web site, you agree to these Terms and Conditions without limitation or qualification.

Use of Materials and Intellectual Property Rights

The copyright in this web site belongs to Shire. All other intellectual property rights are reserved. Shire authorizes you to copy materials published on this web site for noncommercial use only, provided that any copy of these materials which you make retains all copyright and other proprietary notices.

Links to Third Party Web Sites

The web site may from time to time contain hypertext-links to third parties’ web sites. Shire is not responsible for, and accepts no liability in respect of, any information or opinion contained on any other such web site. As Shire has no control over such web sites and because their content is subject to change without notice to Shire, it is the responsibility of the user of the web site to ensure that any information accessed is accurate and that software which is downloaded from that web site is free of viruses or any other items of a destructive nature. Shire accepts no liability whatsoever in respect of any loss, damage, costs or liability incurred through any such downloaded material.

Information Is No Substitute for Consulting a Health Professional

The information on the Web site is intended only to provide knowledge of disease information. This information should not be considered complete and should not be used in place of a visit, call, consultation, or advice of your physician or other health care provider. Shire does not recommend the self-management of health problems. Should you have any health care-related questions, please call or see your physician or other health care provider promptly. You should never disregard medical advice or delay in seeking it because of something you have read here. Information is not necessarily accurate, complete, or current.

Information accessed on the Web site is not exhaustive. Shire makes reasonable efforts to include accurate and current information, wherever possible, but makes no warranties or representations as to its accuracy or completeness. This information is provided “as is” without warranty of any kind, either express or implied, including but not limited to implied warranty of fitness for a particular purpose. Shire is not responsible for computer damage resulting from using the web site.

Shire makes no representation or warranty that access to the web site will be available on a timely basis, will be uninterrupted, or will be error-free. Shire does not warrant that these pages, or the server that makes them available, are free of viruses or other harmful elements. In no event shall Shire, its affiliates and subsidiaries, and their respective officers, directors, employees, agents, representatives, information providers, and licensors and their respective heirs and assigns, be liable for any direct indirect, incidental, consequential, exemplary, special, punitive, or other damages even if informed of the possibility of such damages. The above exclusion may not apply in jurisdictions to the extent that they do not allow the exclusion of implied warranties.

Any personally identifiable information in electronic communications to this web site is governed by Shire’s Privacy Policy. Shire shall be free to use or copy all other information in any such communications, including any ideas, inventions, concepts, techniques or know-how disclosed therein, for any purposes, including disclosure to third parties and/or developing, manufacturing and/or marketing products or services. Information intended for U.S. residents only.

All materials and information appearing on the Web site are intended for U.S. residents only. These Terms and Conditions were last updated: February 4, 2009.

Indications and Detailed Important Risk Information for RECOMBINATE [Antihemophilic Factor (Recombinant)].
See full Prescribing Information.

RECOMBINATE [Antihemophilic Factor (Recombinant)] Important Information

Indications for RECOMBINATE

RECOMBINATE [Antihemophilic Factor (Recombinant)] is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes and for the perioperative management of patients with hemophilia A.

RECOMBINATE is not indicated for von Willebrand’s disease.

Detailed Important Risk Information for RECOMBINATE

You should not use RECOMBINATE if you are allergic to mouse, hamster, or bovine proteins or if you are allergic to any ingredients in RECOMBINATE.

RECOMBINATE is for treating patients with Factor VIII deficiency (hemophilia A), and it is essential that you are diagnosed before using RECOMBINATE.

You should tell your doctor if you have or have had any medical problems; take any medicines, including prescription and non-prescription medicines, dietary supplements and herbal remedies; have any allergies, including allergies to mouse, hamster, or bovine proteins; are nursing; are pregnant; or have been told that you have inhibitors to Factor VIII (because Factor VIII may not work for you).

You could have an allergic reaction to RECOMBINATE. Symptoms of an allergic reaction may include rash or hives, itching, tightness of the throat, chest pain or tightness, difficulty breathing, lightheadedness, dizziness, or fainting. If you have an allergic reaction, call your doctor right away and stop treatment.

Your body may form inhibitors to Factor VIII. Inhibitors are part of your body’s normal defense system. If you form inhibitors, it may stop RECOMBINATE from working properly. Consult with your doctor to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.

The most common side effects are chills, flushing, rash, and nose bleed.

Post marketing adverse reactions have been reported and include the following: inhibitors, rapid heartbeat, bluish coloration of the skin, vomiting, stomach pain, body discomfort, injection site reactions, chest pain, chest discomfort, anaphylactic reaction, hypersensitivity, loss of consciousness, headache, tingling sensation, difficulty breathing, cough, airway swelling, localized swelling, hives, and redness of the skin.

Call your doctor right away about any side effects that bother you or if your bleeding does not stop after taking RECOMBINATE.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for RECOMBINATE full Prescribing Information.